qMate Mini Nucleic Acid Extraction System
Oncology
Breast Cancer Detection Solutions
Key Advantages and Benefits
1. Improved Prognostic Assessment
HER2-positive status helps identify breast cancer with a generally poor prognosis, enabling more informed patient management.
PIK3CA mutation status provides critical insights for prognosis and disease stratification.
2. Enhanced Classification and Diagnosis
HER2 expression levels serve as a key biomarker for precise classification and diagnosis of breast cancer.
PIK3CA mutations further refine diagnostic accuracy and subtype identification.
3. Targeted Therapy Opportunities
HER2-positive patients can benefit from specific targeted therapies, improving treatment efficacy.
PIK3CA and NTRK are actionable targets, driving the development of novel anti-tumor drugs.
4. Effective Treatment Monitoring
Tracking HER2 expression changes allows real-time evaluation of treatment effectiveness, enabling timely adjustments for better clinical outcomes.
5. Personalized Treatment Prediction
HER2 expression levels predict patient responsiveness to certain drug treatments, supporting personalized therapeutic strategies.
Workflow
Ordering Information
|
Catalog No. |
Product Name |
Specification |
Description |
|
121006048 |
HER2 Gene Amplification Digital PCR Detection Kit |
48r |
Chip matched |
|
121008048 |
HER2 Gene Amplification/Exon 20 Insertion Mutation Digital PCR Detection Kit |
48r |
Chip matched |
|
121009048 |
PIK3CA Gene Mutations Digital PCR Detection Kit |
48r |
Chip matched |
|
121013048 |
NTRK Gene Fusion Digital PCR Detection Kit |
48r |
Chip matched |
We have a variety of reference materials available, including colour brochures, technical guides, professional literature and operation videos. If you need to consult or obtain relevant materials, please fill in the information below to contact us.